Uroquinasa (UROKINASE) SYNER MEDICA 500.000 U.I. powder for solution for injection/infusion

Uroquinasa (UROKINASE) SYNER MEDICA 500.000 U.I. powder for solution for injection/infusion
Product Description

Syner-KINASE® is indicated for the lysis of blood clots in the following conditions: - thrombosed intravascular catheters and cannulae
- extensive acute proximal deep vein thrombosis
- acute massive pulmonary embolism
- acute occlusive peripheral arterial disease with limb threatening ischemia

Mana Pharma

  • ES
  • 2024
    On CPHI since
  • 2
    Certificates
  • 25 - 49
    Employees
Company types
Pharmaceutical company
Primary activities
End-product distributor (Wholesale)
Specifications

Mana Pharma

  • ES
  • 2024
    On CPHI since
  • 2
    Certificates
  • 25 - 49
    Employees
Company types
Pharmaceutical company
Primary activities
End-product distributor (Wholesale)

More Products from Mana Pharma (4)

  • ANTICUDE

    Product ANTICUDE

    Anticude is a medicine that is used as an antidote to curing agents, including synthetic curing agents and synthetic ones, in prolonged apnea and in any syndrome involving atony of the striated or smooth fibre musculature. It is also used in the diagnosis and treatment of myasthenia gravis and to aid in th...
  • BIOCORYL 100 MG/ML

    Product BIOCORYL 100 MG/ML

    Biocoryl is indicated for the treatment of potentially malignant ventricular arrhythmias in adults over 18years of age.This medicinal product is administered parenterally (intramuscularly or intravenously). The intravenous route should be reserved for emergencies. 
  • Uroquinasa (UROKINASE) SYNER MEDICA 100.000 U.I. powder for solution for injection/infusion

    Product Uroquinasa (UROKINASE) SYNER MEDICA 100.000 U.I. powder for solution for injection/infusion

    Syner-KINASE® is indicated for the lysis of blood clots in the following conditions: - thrombosed intravascular catheters and cannulae
    - extensive acute proximal deep vein thrombosis
    - acute massive pulmonary embolism
    - acute occlusive peripheral arterial disease with limb threatening ischemia
  • Uroquinasa (UROKINASE) SYNER MEDICA 250.000 U.I. powder for solution for injection/infusion

    Product Uroquinasa (UROKINASE) SYNER MEDICA 250.000 U.I. powder for solution for injection/infusion

    Syner-KINASE® is indicated for the lysis of blood clots in the following conditions: - thrombosed intravascular catheters and cannulae
    - extensive acute proximal deep vein thrombosis
    - acute massive pulmonary embolism
    - acute occlusive peripheral arterial disease with limb threatening ischemi...

Mana Pharma resources (1)

  • News Mana Pharma Positioning and differentiation in the sector

    Since the end of 2020, Mana Pharma, S.L. has played a key role in the distribution of Medicines for Special Situations (MSS) in Spain, contributing, in agreement with the Health Authorities, to alleviate the lack of supply of medicines that occur in our country.